Cargando…
Relationship between HMGB1 and PAI-1 after allogeneic hematopoietic stem cell transplantation
BACKGROUND: Conditioning regimens including total body irradiation (TBI) or cyclophosphamide can mobilize high-mobility group box 1 (HMGB1) to peripheral blood. Additionally, increased plasminogen activator inhibitor (PAI)-1 levels are associated with post-allogeneic hematopoietic stem cell transpla...
Autores principales: | Nomura, Shosaku, Maeda, Yoshinobu, Ishii, Kazuyoshi, Katayama, Yuta, Yagi, Hideo, Fujishima, Naoto, Ota, Shuichi, Moriyama, Masato, Ikezoe, Takayuki, Miyazaki, Yasuhiko, Hayashi, Kunio, Fujita, Shinya, Satake, Atsushi, Ito, Tomoki, Kyo, Taiichi, Tanimoto, Mitsune |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4723029/ https://www.ncbi.nlm.nih.gov/pubmed/26848281 http://dx.doi.org/10.2147/JBM.S93008 |
Ejemplares similares
-
Assessment of soluble cytotoxic T lymphocyte-associated antigen-4, transforming growth factor β(1), and platelet-derived microparticles during dasatinib therapy for patients with chronic myelogenous leukemia
por: Nomura, Shosaku, et al.
Publicado: (2018) -
Effects of teneligliptin on PDMPs and PAI-1 in patients with diabetes on hemodialysis
por: Okuda, Yoshinori, et al.
Publicado: (2016) -
Evaluation of a biosimilar granulocyte colony-stimulating factor (filgrastim XM02) for peripheral blood stem cell mobilization and transplantation: a single center experience in Japan
por: Yoshimura, Hideaki, et al.
Publicado: (2017) -
Evaluation of thrombosis-related biomarkers before and after therapy in patients with multiple myeloma
por: Nomura, Shosaku, et al.
Publicado: (2018) -
Disseminated intravascular coagulation observed following treatment with gemtuzumab ozogamicin for relapsed/refractory acute promyelocytic leukemia
por: AZUMA, YOSHIKO, et al.
Publicado: (2016)